SCHEMBL10264709

SCHEMBL10264709

CCC(C)(CCCCCC(O)CCCCCC(C)(CC)c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.45
ACACA Q13085 1/20 0.45
RIPK1 Q13546 2/20 0.41
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
SIGMAR1 Q99720 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CSNK1E P49674 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34
FFAR1 O14842 1/20 0.34
TRPA1 O75762 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15355691 0.91 RIPK1 (0.37) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL15355692 0.88 RIPK1 (0.39) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL19176126 0.87 ACACB (0.45) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL6180287 0.87 ACACB (0.45) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL12092767 0.86 ACACB (0.38) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL19678191 0.86 ACACB (0.44) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL19682100 0.86 ACACB (0.44) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL13106139 0.86 ACACB (0.44) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL13106114 0.85 RIPK1 (0.42) ACACBACACARIPK1CYP2C19HIF1A
SCHEMBL6196644 0.85 ACACB (0.41) ACACBACACARIPK1CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404890-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-11 EP disclosed